ALK c.3907G>A ;(p.E1303K)

Variant ID: 2-29430068-C-T

NM_004304.4(ALK):c.3907G>A;(p.E1303K)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Heterogeneous responses and resistant mechanisms to crizotinib in ALK-positive advanced non-small cell lung cancer.

Thoracic Cancer
Kang, Jin J; Chen, Hua-Jun HJ; Zhang, Xu-Chao XC; Su, Jian J; Zhou, Qing Q; Tu, Hai-Yan HY; Wang, Zhen Z; Wang, Bin-Chao BC; Zhong, Wen-Zhao WZ; Yang, Xue-Ning XN; Chen, Zhi-Hong ZH; Ding, Yan Y; Wu, Xue X; Wang, Mei M; Fu, Jian-Gang JG; Yang, Zhenfan Z; Zhang, Xian X; Shao, Yang W YW; Wu, Yi-Long YL; Yang, Jin-Ji JJ
Publication Date: 2018-09

Variant appearance in text: ALK: E1303K
PubMed Link: 29978950
Variant Present in the following documents:
  • Main text
  • TCA-9-1093-s006.xlsx, sheet 1
  • TCA-9-1093.pdf
View BVdb publication page



Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.

Cell Reports
Way, Gregory P GP; Sanchez-Vega, Francisco F; La, Konnor K; Armenia, Joshua J; Chatila, Walid K WK; Luna, Augustin A; Sander, Chris C; Cherniack, Andrew D AD; Mina, Marco M; Ciriello, Giovanni G; Schultz, Nikolaus N; , ; Sanchez, Yolanda Y; Greene, Casey S CS
Publication Date: 2018-04-03

Variant appearance in text: ALK: 3907G>A
PubMed Link: 29617658
Variant Present in the following documents:
  • NIHMS958974-supplement-5.xlsx, sheet 1
View BVdb publication page